Mouse Model Results

Ever stand up after hours at a desk and your knees sound like a rusty hinge? Or finish a weekend run and feel like your joints mailed you a strongly worded complaint by Tuesday?

In this Deep Dive, we unpack a 2025 paper from Discovery Medicine titled “Urolithin B promotes meniscal regeneration and prevents the development of osteoarthritis in mice.” The headline is big: not just less inflammation or less pain signaling, but actual meniscus repair signals in a disease model that normally accelerates joint breakdown.

We break down what Urolithin B is, why food sources aren’t reliable for most people, and how this molecule appears to flip joint cells from destruction mode to construction mode by suppressing inflammatory cytokines and tissue-chewing enzymes (like MMP-13) while boosting cartilage-building programs (like SOX9, collagen, and VEGF). We also connect the mechanism to the real-world “why” behind delivering Urolithin B directly (as discussed in the episode).

-

Article Discussed in Episode:

Urolithin B Promotes Meniscal Regeneration and Prevents the Development of Osteoarthritis in Mice

-

Key Quotes From Dr. Mike:

• “(Urolithin B) is tackling what many would call the holy grail of joint health… regeneration.”

• “(Urolithin B) literally flipped the switch from a catabolic breakdown state to an anabolic build-up state.”

• “You’re not masking a symptom, you’re trying to reboot the regenerative machinery.”

• “Defend, protect, and rebuild all in one molecule." (In regards to Urolithin B)

-

Key points

• The big promise: regeneration — not just symptom relief.

• What Urolithin B is: a gut-derived metabolite from ellagic-acid-rich foods (pomegranate, walnuts, berries).

• Why diet isn’t enough for many: large portion of people may be low/non-producers due to microbiome variability.

• Meniscus 101: fibrocartilage “shock absorber” between femur and tibia; when it fails, OA risk rises fast.

• Current standard care problem: many options manage symptoms more than they restore tissue.

• In vitro findings: Urolithin B was non-toxic and calmed IL-1β–triggered inflammatory signaling.

• Stops the demolition crew: reduced destructive ECM enzymes (highlighted: MMP-13, ADAMTS enzymes).

• Starts the construction crew: increased cartilage matrix building blocks (collagens, aggrecan).

• Flips genetic switches: boosted transcription factors tied to cartilage formation (spotlight: SOX6/SOX9).

• Supports “supply lines”: increased VEGF (angiogenesis signal), relevant given meniscus’ poor blood supply.

• In vivo mouse OA model: meniscus-injury OA developed as expected in controls; EuroB-treated animals showed less erosion and better structure.

• Consistent mechanism across dish → animal: inflammatory markers down, matrix destruction down, repair signals up.

-

Episode timeline 

• 0:00–0:44 — Cold open: creaky joints, “repair the hinge” idea

• 0:44–1:22 — Episode mission + 2025 paper intro (Urolithin B, meniscus regeneration, OA prevention in mice)

• 1:34–2:17 — What Urolithin B is + “signal” framing

• 2:48–4:11 — Meniscus basics, OA problem, limits of symptom-based treatments

• 4:18–6:12 — Petri-dish phase: safety + IL-1β inflammation model + suppression of cytokines/destructive enzymes

• 6:18–8:13 — Rebuild signals: collagens/aggrecan, SOX6/SOX9, VEGF, proliferation markers

• 8:57–10:40 — Mouse OA model: structural improvements + tissue protein markers confirm mechanism

• 10:48–11:46 — “Triple threat” summary: anti-inflammatory, anti-catabolic, anabolic

• 11:49–12:55 — Why food conversion is unreliable (microbiome “lottery”) + direct-delivery rationale

• 12:59–14:31 — Big-picture future: “inducing repair” + closing call-to-action / wrap

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight:

Website

Instagram

YouTube

Facebook